http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872005-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102872005-B |
| titleOfInvention | Application of the glycyrrhizin in treatment pneumonia medicine is prepared |
| abstract | The present invention relates to application of the glycyrrhizin in treatment pneumonia medicine is prepared, the protection test and mouse S. aureus L-forms pulmonary inflammation model damaged by rabbit erythrocyte hemolytic test, human squamous lung cancer (A549) confirms its therapeutic action infected S. aureus L-forms.Compared with antibiotic therapy, had using Radix Glycyrrhizae extract for treating and had no drug resistance, the characteristics of cure rate is high. |
| priorityDate | 2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.